Our commercial operations in Ireland are managed out of our offices in London. The portfolio comprises a number of affordable, high quality generic medicines. We have a manufacturing plant at Cashel in Ireland. We have strength in development of generic and value added generic products for European markets. We have partnerships with local marketing and distribution companies to ensure smooth operations. Through various endeavours, we support the Government’s initiative in bringing down overall healthcare costs.
At a Glance
Launched Operations: 2003
No. of Molecules: 7
Leading Molecules: Rosuvastatin, Clarithromycin
Presence in Therapeutic Segments: Anti-infectives, Central Nervous System (CNS), Cardiovascular
General Manager-Portfolio Management,
RANBAXY EUROPE LIMITED
Building 4, Chiswick Park,
566 Chiswick High Road,
London, W4 5YE,
|+442 -087 425 250|
|+442 -087 425 291|
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.